@FierceBiotech: Merck KGaA puts a lead cancer drug on the chopping block; Threshold craters. Report | Follow @FierceBiotech
@JohnCFierce: I've got news of a sizable new biotech fund coming up at 6 EST. Stay tuned. | Follow @JohnCFierce
> Celgene ($CELG) and AstraZeneca ($AZN) have launched their collaboration around the PD-1 checkpoint inhibitor durvalumab. Investigators are starting four trials of the drug and therapeutic combinations against a range of blood cancers including non-Hodgkin's lymphoma, myelodysplastic syndromes and multiple myeloma. Release
> Gilead Sciences ($GILD), raking in revenue with its blockbuster hepatitis C therapies, is again talking up its plans for M&A, with R&D chief Norbert Bischofberger telling the Financial Times "we have incredible cash flows and we are looking for opportunities." Story
> Expanding her focus on the drug industry, Hillary Clinton has introduced a proposal to limit the effectiveness of tax inversions. More
Medical Device News
@FierceMedDev: ICYMI Friday: Google Life Sciences edges into Theranos terrain with needle-free, micro blood draw patent filing. Article | Follow @FierceMedDev
@VarunSaxena2: I've never seen a team invent so many ways to lose as the Detroit Lions! I knew it was coming! Unsure of call but it's the Lions after all. | Follow @VarunSaxena2
@EmilyWFierce: ICYMI from FiercePharma: Cancer drug prices vary across the globe as countries strike deals with Big Pharma: Study. More | Follow @EmilyWFierce
> Danaher tags its industrial unit with the name 'Fortive' as part of the company split. More
> Cepheid nabs FDA OK for point-of-care flu test. Article
Pharma News
@FiercePharma: Scientists and ethicists debate 'gene editing' for animal health. More from FierceAnimalHealth | Follow @FiercePharma
@EricPFierce: ICYMI Friday: Sun to launch generic Gleevec Feb. 1 but has said it won't be manufacturing it at troubled Halol plant. Report | Follow @EricPFierce
@CarlyHFierce: ICYMI Friday: If Pfizer's consumer health unit goes up for grabs, Reckitt's interested, CEO says. Report | Follow @CarlyHFierce
> Clinton keeps heat on drug industry with tax proposal for inversion deals. Report
> GSK delays Japanese drug launch after Catalent closes plant to investigate tampering. Article
Animal Health News
> Animalytix expands to Canada with acquisition of animal-health data service. Item
> Flu expert warns against USDA move to build bird flu vaccine stockpile. More
> Scientists and ethicists debate 'gene editing' for animal health. Story
> UMass seeks 5,000 dogs for study of genes and brain disorders. Report
> Supreme Court declines to review case on legality of online veterinary services. Article
Biotech IT News
> CDC taps uBiome for large-scale microbiome sequencing initiative. Report
> Genomics England picks Skyscape to provide cloud computing power to sequencing drive. Story
> AstraZeneca wants its scientists to interact on social media. More
> Kite teams with GE in bid to lower T cell production costs through automation. Item
> Venter's HLI adds genome interpretation software in Cypher Genomics buyout. Article
Pharma Marketing News
> Olympic snowboarder Kelly Clark 'vlogs' her acne-med experience for Sun Pharma. More
> AbbVie's Imbruvica, Amgen's Kyprolis shine at annual ASH meeting. Report
> GSK delays Japanese hair-loss treatment launch on Catalent plant problems. Item
> European group joins movement to stop industry cash flows to CME. Story
> With new rivals, Baxalta faces a hemophilia smackdown. So why is Shire bidding? Article